KN
Knowles Corp

570
Loading...
Loading...
News
all
press releases
Knowles Reports Q4 & Full Year 2024 Financial Results and Provides Outlook for Q1 2025
Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components for innovative technologies, including capacitors, radio frequency ('RF') filters, advanced medtech...
Business Wire·7mo ago
News Placeholder
More News
News Placeholder
Knowles to Release Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
Knowles Corporation (NYSE: KN) a leading manufacturer of specialty electronic components for innovative technologies, including capacitors, radio frequency ('RF') filters, advanced medtech...
Business Wire·8mo ago
News Placeholder
Eli Lilly's Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea
Shelby Knowles / Bloomberg via Getty ImagesKey TakeawaysEli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month.Weight...
Investopedia Headlines·8mo ago
News Placeholder
Syntiant completes acquisition of Knowles' Consumer MEMS Microphone division
Syntiant completes acquisition of Knowles' Consumer MEMS Microphone division...
Yahoo! Finance: News·9mo ago
News Placeholder
Knowles Corporation Completes the Sale of Its Consumer MEMS Microphone Business to Syntiant
Knowles Corporation (NYSE: KN) ('Knowles' or the 'Company'), a leading manufacturer of specialty electronic components for innovative technologies, including capacitors, radio frequency ('RF...
Business Wire·9mo ago
News Placeholder
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shelby Knowles / Bloomberg via Getty ImagesKey TakeawaysShares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe...
Investopedia Headlines·9mo ago
News Placeholder
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Shelby Knowles / Bloomberg / Getty ImagesKey TakeawaysEli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the...
Investopedia Headlines·9mo ago
News Placeholder
Knowles Appoints Laura Angelini to its Board of Directors
Knowles Corporation (NYSE: KN), a leading global supplier of high-performance electronics for demanding applications, including capacitors and radio frequency (RF) filters, advanced medtech...
Business Wire·9mo ago
News Placeholder
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Shelby Knowles / Bloomberg / Getty ImagesKey TakeawaysPatients taking Eli Lilly's Zepbound lost more weight on average than those on Novo Nordisk's Wegovy in a new clinical study.Zepbound patients...
Investopedia Headlines·9mo ago
News Placeholder
Tyson Stock Surges as Higher Beef and Chicken Prices Boost Results
Shelby Knowles / Bloomberg via Getty ImagesKey TakeawaysTyson Foods posted better-than-expected results for the fourth quarter as higher beef and chicken prices lifted sales.Beef sales gained 4.6...
Investopedia Headlines·10mo ago

Latest KN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.